PMC:7324763 / 75510-75768
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1212 | 72-87 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T1213 | 94-102 | SP_7 | denotes | COVID-19 |
T1214 | 161-176 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T1215 | 181-186 | NCBITaxon:10239 | denotes | viral |
T53714 | 72-87 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T16797 | 94-102 | SP_7 | denotes | COVID-19 |
T5076 | 161-176 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T63377 | 181-186 | NCBITaxon:10239 | denotes | viral |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T530 | 94-102 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T32605 | 72-87 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T75442 | 161-176 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2109 | 103-111 | Species | denotes | patients | Tax:9606 |
2120 | 94-102 | Disease | denotes | COVID-19 | MESH:C000657245 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32655581-32266987-34771857 | 253-256 | 32266987 | denotes | 262 |
TEST0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32655581-235-242-3171430 | 253-256 | ["32266987"] | denotes | 262 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32655581-32266987-34771857 | 253-256 | 32266987 | denotes | 262 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T456 | 0-258 | Sentence | denotes | Additionally, one retrospective observational study examined the use of corticosteroids in 31 COVID-19 patients, and reported no significant association between corticosteroids and viral clearance time, hospital length of stay, or duration of symptoms (262). |